Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wheatley

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
The Cochrane Database of Systematic Reviews|March 19, 2010
Bisphosphonates in multiple myelomaRahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, et al.
Blood|August 10, 2012
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trialJohn A Liu Yin, Michelle A O'Brien, Robert K Hills, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trialsNatalie J Ives, Keith Wheatley, Rebecca L Stowe, et al.
Cancers|January 21, 2022
Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB TrialSimon Bailey, Nicolas André, Lorenza Gandola, et al.
Transplantation|March 25, 2009
Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysisJason Moore, Lee Middleton, Paul Cockwell, et al.
BMJ (Clinical Research Ed.)|August 18, 2004
Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patientsNatalie J Ives, Rebecca L Stowe, Joanna Marro, et al.
Cancer|February 23, 2007
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatmentAlan K Burnett, Donald Milligan, Archie G Prentice, et al.
Cancers|March 28, 2024
Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. <i>Cancers</i> 2022, <i>14</i>, 374Simon Bailey, Nicolas André, Lorenza Gandola, et al.
British Journal of Haematology|July 26, 2002
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trialAlan K Burnett, Keith Wheatley, Anthony H Goldstone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remissionAlan K Burnett, Anthony Goldstone, Robert K Hills, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
The Cochrane Database of Systematic Reviews|March 19, 2010
Bisphosphonates in multiple myelomaRahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, et al.
Blood|August 10, 2012
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trialJohn A Liu Yin, Michelle A O'Brien, Robert K Hills, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trialsNatalie J Ives, Keith Wheatley, Rebecca L Stowe, et al.
Cancers|January 21, 2022
Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB TrialSimon Bailey, Nicolas André, Lorenza Gandola, et al.
Transplantation|March 25, 2009
Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysisJason Moore, Lee Middleton, Paul Cockwell, et al.
BMJ (Clinical Research Ed.)|August 18, 2004
Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patientsNatalie J Ives, Rebecca L Stowe, Joanna Marro, et al.
Cancer|February 23, 2007
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatmentAlan K Burnett, Donald Milligan, Archie G Prentice, et al.
Cancers|March 28, 2024
Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. <i>Cancers</i> 2022, <i>14</i>, 374Simon Bailey, Nicolas André, Lorenza Gandola, et al.
British Journal of Haematology|July 26, 2002
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trialAlan K Burnett, Keith Wheatley, Anthony H Goldstone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remissionAlan K Burnett, Anthony Goldstone, Robert K Hills, et al.
Pageof 15